Thursday, December 16, 2021
Biochemist Andrew Truman and his lab have received grants totaling near $2M to fund the search for new cancer and neurological treatments.
The Truman lab’s focus is on chaperone proteins, strings of proteins that are wound and folded to create complex processes. Understanding these processes and how they affect diseases is key to the team’s research.
Read more from the College of Liberal Arts and Sciences.